Levacetylleucine
Tier C — Watch / tradeLevacetylleucine
Targets：Not applicable
Brand：AQNEURSA
Indications (approved)：C型尼曼匹克病
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LACE-001 | - | (S)-benzyl 2-amino-4-methylpentanoate 4-methylbenzenesulfonate |
| LACE-002 | - | (S)-benzyl 2-acetamido-4-methylpentanoate |
| L-Acetylleucine | - | - |
Frequently asked questions
What are the approved indications of Levacetylleucine?
Approved indications include: C型尼曼匹克病.
When does the Levacetylleucine patent expire?
No public expiry year is available for Levacetylleucine yet; this page updates once verified.
How many synthesis routes are recorded for Levacetylleucine?
1 synthesis routes are recorded; the shortest is 2 steps with 100 mg (L-Acetylleucine) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Levacetylleucine intermediates?
All intermediates in Levacetylleucine routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Levacetylleucine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27